StonvexLoading…
StonvexCore line items from FSLY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $173.02M | $624.02M | $451.41M | $293.18M |
Operating Income | $-23.89M | $-119.00M | $-103.91M | $-75.12M |
Net Income | $-20.52M | $-121.68M | $-106.17M | $-76.69M |
EPS (Diluted) | $-0.13 | $-0.83 | $-0.73 | $-0.53 |
Total Assets | $1.51B | $1.50B | $1.47B | $1.46B |
Total Liabilities | $536.38M | $569.90M | $533.64M | $520.53M |
Cash & Equivalents | $146.67M | $180.56M | $113.13M | $82.49M |
Free Cash Flow OCF − CapEx | $7.84M | $65.75M | $53.51M | $30.63M |
Shares Outstanding | 156.40M | 151.50M | 145.75M | 144.54M |